Jun Qi
Impact in
- Hematology top 0.2%
- Multiple Myeloma Research and Treatments
- Molecular Biology top 0.5%
- Protein Degradation and Inhibitors
- Ubiquitin and proteasome pathways
- Histone Deacetylase Inhibitors Research
- Epigenetics and DNA Methylation
- Genomics and Chromatin Dynamics
- Cancer-related gene regulation
Papers in
- Hematology 42
- Multiple Myeloma Research and Treatments 32
-
- Protein Degradation and Inhibitors 80
- Ubiquitin and proteasome pathways 33
- Histone Deacetylase Inhibitors Research 28
- Epigenetics and DNA Methylation 14
- Chromatin Remodeling and Cancer 10
- Co-authors
- James E. Bradner (49 shared papers)Andrew L. Kung (13 shared papers)Junwei Shi (4 shared papers)Christopher R. Vakoc (2 shared papers)Scott J. Rodig (7 shared papers)James E. Bradner (18 shared papers)Scott C. Kogan (1 shared paper)Agustin Chicas (1 shared paper)
- Journals
- Blood (21 papers)Journal of Medicinal Chemistry (6 papers)Leukemia (5 papers)Oncogene (4 papers)Molecular Cancer Therapeutics (4 papers)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Jun Qi
183 papers receiving 10.1k citations
Jun Qi's Hit Papers
Peers
Comparison fields: 5 of 145
- Hematology 2.1k
- Molecular Biology 7.8k
- Oncology 1.7k
- Cancer Research 671
- Genetics 391
Countries citing papers authored by Jun Qi
This map shows the geographic impact of Jun Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Qi more than expected).
Fields of papers citing papers by Jun Qi
This network shows the impact of papers produced by Jun Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Qi. The network helps show where Jun Qi may publish in the future.
Co-authors
The 25 scholars most cited alongside Jun Qi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 194 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia Hit paper breakdown → | 2011 | 1464 |
| 2 | The dTAG system for immediate and target-specific protein degradation Hit paper breakdown → | 2018 | 721 |
| 3 | Discovery and Characterization of Super-Enhancer-Associated Dependencies in Diffuse Large B Cell Lymphoma Hit paper breakdown → | 2013 | 559 |
| 4 | Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition Hit paper breakdown → | 2013 | 485 |
| 5 | 2012 | 326 | |
| 6 | 2013 | 322 | |
| 7 | 2012 | 306 | |
| 8 | 2016 | 238 | |
| 9 | 2015 | 228 | |
| 10 | 2013 | 217 | |
| 11 | 2018 | 189 | |
| 12 | 2016 | 168 | |
| 13 | 2015 | 168 | |
| 14 | 2013 | 166 | |
| 15 | 2014 | 161 | |
| 16 | 2018 | 159 | |
| 17 | 2013 | 147 | |
| 18 | 2013 | 144 | |
| 19 | 2019 | 141 | |
| 20 | 2014 | 131 |
About Jun Qi
Jun Qi is a scholar working on Hematology, Molecular Biology, Biotechnology, Oncology and Pharmacology, having authored 194 papers that have together received 10.3k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (80 papers), Ubiquitin and proteasome pathways (33 papers), Multiple Myeloma Research and Treatments (32 papers), Histone Deacetylase Inhibitors Research (28 papers), Marine Sponges and Natural Products (14 papers), Epigenetics and DNA Methylation (14 papers), Microbial Natural Products and Biosynthesis (13 papers) and Chromatin Remodeling and Cancer (10 papers). The work is most often cited by research in Hematology (2.1k citations), Molecular Biology (7.8k citations), Oncology (1.7k citations), Cancer Research (671 citations) and Genetics (391 citations). Jun Qi has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include James E. Bradner, Andrew L. Kung, Junwei Shi, Christopher R. Vakoc, Scott J. Rodig, James E. Bradner, Scott C. Kogan, Agustin Chicas, S Lowe and Patrick Andrew Brown. Their work appears in journals such as Blood, Journal of Medicinal Chemistry, Leukemia, Oncogene and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.